#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Asthma Dermatitis atopic Dementia Alzheimer's type Type 2 diabetes mellitus Breast cancer metastatic Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Gastroenteropancreatic neuroendocrine tumour disease Neutropenia Ehlers-Danlos syndrome Uterine leiomyosarcoma Arrhythmogenic right ventricular dysplasia Kawasaki's disease Haematological malignancy Cutaneous lupus erythematosus Diabetes insipidus Neurofibroma Depression Retinal artery occlusion Bulbospinal muscular atrophy congenital Hyperchylomicronaemia Ovarian cancer stage III More trials…

    Learn about Rare Diseases

    Uterine leiomyosarcoma – Trials in Disease Glomerulonephritis membranous – Trials in Disease Haemophilia A without inhibitors Bronchiolitis obliterans syndrome – Life with Disease Bronchiolitis obliterans syndrome – Trials in Disease Loeys-Dietz syndrome – Life with Disease Ocular melanoma Friedreich’s ataxia – Diagnostics Malignant fibrous histiocytoma Methylmalonic acidaemia – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Indacaterol Maleate Cetrelimab Ht-29-B Enalapril CHLOROQUINE PHOSPHATE INF904 ABIRATERONE DECANOATE Panobinostat Avacopan Citicoline Sodium S095035 Sodium Cromoglicate Azithromycin Ondansetron Hydrochloride Ranibizumab Rhh646 Everolimus Avb-101 Psilocybine Vusolimogene Oderparepvec More therapies…

    Learn about Your Condition

    Hereditary optic atrophy Tonsillitis Right ventricular dysfunction Autoimmune hepatitis Breast cancer Extraskeletal ossification Alcoholism Giardiasis Oropharyngeal cancer Binge eating Nephropathy Sinusitis bacterial Neutropenia Pyoderma gangrenosum Supranuclear palsy More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. CHRU de Tours- Hôpital Trousseau

CHRU de Tours- Hôpital Trousseau

Avenue De La Republique, Chambray Les Tours, 37170, France

Want to learn more about this study or check if you can participate? Contact us.

  • A Study of Danicamtiv for Adults with Symptomatic Genetic and Familial Dilated Cardiomyopathy to Test if it Improves Heart Function and Exercise Ability

    Recruiting

    4 1
    Investigated Drugs:
    • Danicamtiv
    Belgium Denmark France Hungary Italy The Netherlands +3

  • Study on the Effects of Nefopam and Sodium Chloride for Pain Relief After Total Hip Replacement Surgery

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Hip arthroplasty
    Investigated Drugs:
    • Nefopam
    • Sodium Chloride
    France

  • Study Comparing Subcutaneous and Intravenous Nivolumab and Relatlimab for Patients with Untreated Metastatic or Unresectable Melanoma

    Recruiting

    3 1 1
    Investigated Drugs:
    • Nivolumab
    • Relatlimab
    Austria Belgium Czechia Finland France Germany +5

  • Study on Joint Health in Hemophilia A and B Patients Using Efmoroctocog Alfa or Eftrenonacog Alfa

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Factor IX deficiency
    • Factor VIII deficiency
    Investigated Drugs:
    • Efmoroctocog Alfa
    • Eftrenonacog Alfa
    Bulgaria Croatia Czechia France Hungary Ireland +4

  • A study to evaluate the effect of olpasiran on major cardiovascular events in patients with atherosclerotic cardiovascular disease and high levels of lipoprotein(a)

    Not recruiting

    3 1
    Austria Belgium Bulgaria Czechia Denmark Estonia +16

  • Study on Chemotherapy with Levoleucovorin, Capecitabine, and Folinic Acid for Patients Aged 70+ After Stage III Colon Cancer Surgery

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Colon cancer
    Investigated Drugs:
    • Levoleucovorin
    • Capecitabine
    • Fluorouracil
    Belgium France

  • Study Comparing Abatacept and Tocilizumab for Adults with Rheumatoid Arthritis Not Responding to Previous Treatments

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • Abatacept
    • Tocilizumab
    France

  • Study on the Effectiveness of Enlicitide Chloride in Reducing Cardiovascular Events in Patients with Atherosclerotic Cardiovascular Disease

    Not recruiting

    3 1
    Investigated Diseases:
    • Type IIa hyperlipidaemia
    Denmark France Germany Hungary Italy The Netherlands +3

  • Study on the Long-Term Safety and Effectiveness of Upadacitinib for Patients with Moderate to Severe Crohn’s Disease

    Not recruiting

    3 1
    Investigated Drugs:
    • Upadacitinib
    Austria Belgium Croatia Czechia Denmark France +13

  • Study on Adding Ipilimumab to Atezolizumab and Bevacizumab for Patients with Liver Cancer Receiving First-Line Treatment

    Not recruiting

    4 1 1 1
    Investigated Diseases:
    • Hepatic cancer
    Investigated Drugs:
    • Atezolizumab
    • Bevacizumab
    • Ipilimumab
    France
1 2
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!